-
First Patient Enrolled in SNR High Dose High Intensity Study with MindMaze Therapeutics
MindMaze Therapeutics Holding SA (SIX: MMTX), today announced that the SwissNeuroRehab Consortium (www.swissneurorehab.ch) has enrolled its first patient in the High-Dose, High-Intensity (HDHI) neurorehabilitation study – Advancing At-Home Reimbursement Strategy in Europe. The study is a multicenter feasibility and implementation project evaluating whether HDHI neurorehabilitation can be delivered sustainably within a continuum-of-care framework. The study is powered by MindMaze’s precision neurotherapeutic platform (including MindMotionGO, Izar, and Companion). The study targets 300 minutes of active training per week, spanning a 4-6 week inpatient phase, an 8-12 week outpatient/home phase, and a follow-up at 15 months from inclusion. Recruitment is active at Lausanne University Hospital (CHUV), Institution de Lavigny, Rehaklinik Valens, Swiss…
-
New HES-SO Microcertification REHABTECH
SwissNeuroRehab is pleased to announce the launch of a new HES-SO microcertification course, RehabTech – Technology and Neurorehabilitation (2 ECTS), developed as part of the SwissNeuroRehab programme under the sub-project “Education & Training” (SP5). Taking place from 21–23 May 2026 at the Neurorehabilitation Research Center in Lavigny, this course is designed for healthcare professionals and researchers working in rehabilitation and related fields. It offers a unique opportunity to explore cutting-edge topics such as body and space perception, neuroprosthetics, and the integration of health technologies and AI in rehabilitation pathways. The 3-day programme combines lectures, hands-on laboratory sessions, and interdisciplinary workshops, fostering collaboration across professional backgrounds. Registration is open until 1…
-
Annual General Assembly 2025
This year, our annual general meeting was held on the shores of Lake Lucerne in the beautiful Swiss village of Vitznau. It was hosted by one of the SNR partners, the Lake Lucerne Institute, in the impressive Kultur Kulinarik Vitznau building. The fantastic organization and attendance of over 50 SNRs members, set the foundation for a great meeting. The meeting was kicked off by a warm welcome from the meeting’s host and SP5 lead, Chris Awai, followed by an introduction by the SNR project lead, Andrea Serino. The morning consisted of presentations and updates from each of the five subprojects, highlighting the progress made over the last year. Some successes…
-
SWISSNEUROREHAB: first Patient Public Involvement (PPI) Day on March 31st 2025
Integrating patient perspective into SwissNeuroRehab. The SwissNeurorehab (SNR) project aims at improving the autonomy of people undergoing neurorehabilitation and to facilitate their return to their social and professional life, at their best conditions. To do that, SNR will develop and assess the efficacy and efficiency of a new model of care for neurorehabilitation of acquired brain injury (ABI) and spinal cord injury (SCI) that improves the continuum of care and boost therapy delivery via neurotechnologies and Digital Therapeutics (DTx). To support patient involvement and by then increase the value of the future new model of care from the point of view of patients and their relatives, SwissNeuroRehab has created a…
